These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3422167)

  • 1. Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML).
    Weh HJ; Kuse R; Hoffmann R; Seeger D; Suciu S; Kabisch H; Ritter J; Hossfeld DK
    Blut; 1988 Jan; 56(1):19-26. PubMed ID: 3422167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.
    Kalwinsky DK; Raimondi SC; Schell MJ; Mirro J; Santana VM; Behm F; Dahl GV; Williams D
    J Clin Oncol; 1990 Jan; 8(1):75-83. PubMed ID: 2295913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of karyotype in acute myelogenous leukemia.
    Arthur DC; Berger R; Golomb HM; Swansbury GJ; Reeves BR; Alimena G; Van Den Berghe H; Bloomfield CD; de la Chapelle A; Dewald GW
    Cancer Genet Cytogenet; 1989 Jul; 40(2):203-16. PubMed ID: 2766244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
    Ahmad F; Dalvi R; Das BR; Mandava S
    Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic prognostic factors in childhood acute myeloid leukemia].
    Reinhardt D; Von Neuhoff C; Sander A; Creutzig U
    Klin Padiatr; 2012 Oct; 224(6):372-6. PubMed ID: 22821298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases.
    Fenaux P; Preudhomme C; Laï JL; Morel P; Beuscart R; Bauters F
    Br J Haematol; 1989 Sep; 73(1):61-7. PubMed ID: 2803981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia.
    Stasi R; Del Poeta G; Masi M; Tribalto M; Venditti A; Papa G; Nicoletti B; Vernole P; Tedeschi B; Delaroche I
    Cancer Genet Cytogenet; 1993 May; 67(1):28-34. PubMed ID: 8504396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.
    Harrison CJ; Hills RK; Moorman AV; Grimwade DJ; Hann I; Webb DK; Wheatley K; de Graaf SS; van den Berg E; Burnett AK; Gibson BE
    J Clin Oncol; 2010 Jun; 28(16):2674-81. PubMed ID: 20439644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between chromosomal pattern, cytological subtypes, response to therapy, and survival in acute myeloid leukaemia.
    Li YS; Khalid G; Hayhoe FG
    Scand J Haematol; 1983 Mar; 30(3):265-77. PubMed ID: 6574588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of residual normal metaphases in acute myelogenous leukemia patients presenting with abnormal karyotype.
    Ghaddar HM; Pierce S; Reed P; Estey EH
    Leukemia; 1995 May; 9(5):779-82. PubMed ID: 7769840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
    Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
    Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
    Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent cytogenetic abnormalities observed in complete remission of acute myeloid leukemia do not necessarily mark preleukemic cells.
    Raynaud SD; Brunet B; Chischportich M; Bayle J; Gratecos N; Pesce A; Dujardin P; Flandrin G; Ayraud N
    Leukemia; 1994 Feb; 8(2):245-9. PubMed ID: 8309249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.
    Schoch C; Haferlach T; Haase D; Fonatsch C; Löffler H; Schlegelberger B; Staib P; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
    Br J Haematol; 2001 Jan; 112(1):118-26. PubMed ID: 11167792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute leukemia treated with intensive chemotherapy in patients with a history of previous chemo- and/or radiotherapy: prognostic significance of karyotype and preceding myelodysplastic syndrome. Groupe Francais de Cytogénétique Hématologique (GFCH).
    Leukemia; 1994 Jan; 8(1):87-91. PubMed ID: 8289504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wierzbowska A; Wawrzyniak E; Siemieniuk-Rys M; Kotkowska A; Pluta A; Golos A; Robak T; Szarawarska M; Jaskowiec A; Duszenko E; Rybka J; Holojda J; Grosicki S; Pienkowska-Grela B; Woroniecka R; Ejduk A; Watek M; Wach M; Mucha B; Skonieczka K; Czyzewska M; Jachalska A; Klonowska A; Iliszko M; Knopinska-Posluszny W; Jarmuz-Szymczak M; Przybylowicz-Chalecka A; Gil L; Kopacz A; Holowiecki J; Haus O
    Leuk Lymphoma; 2017 Apr; 58(4):889-897. PubMed ID: 27561449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.